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Expression of yeast mitochondrial genes depends on specific translational activators acting on the 5-untranslated region
of their target mRNAs. Mss51p is a translational factor for cytochrome c oxidase subunit 1 (COX1) mRNA and a key player
in down-regulating Cox1p expression when subunits with which it normally interacts are not available. Mss51p probably
acts on the 5-untranslated region of COX1 mRNA to initiate translation and on the coding sequence itself to facilitate
elongation. Mss51p binds newly synthesized Cox1p, an interaction that could be necessary for translation. To gain insight
into the different roles of Mss51p on Cox1p biogenesis, we have analyzed the properties of a new mitochondrial protein,
mp15, which is synthesized in mss51 mutants and in cytochrome oxidase mutants in which Cox1p translation is
suppressed. The mp15 polypeptide is not detected in cox14 mutants that express Cox1p normally. We show that mp15 is
a truncated translation product of COX1 mRNA whose synthesis requires the COX1 mRNA-specific translational activator
Pet309p. These results support a key role for Mss51p in translationally regulating Cox1p synthesis by the status of
cytochrome oxidase assembly.
INTRODUCTION
Biogenesis of eukaryotic cytochrome c oxidase (COX), the ter-
minal enzyme of the mitochondrial respiratory chain, involves
the coordinated action of two genomes. Three proteins, en-
coded in the mitochondrial DNA (mtDNA), form the catalytic
core with the heme A and copper prosthetic groups of the
enzyme. The other nine to 10 subunits, encoded in nuclear
DNA, interact with the core subunits to form a stable COX
complex. In addition to the structural subunits, COX biogene-
sis requires the assistance of at least 20 other nuclear gene
products some of which are essential for the expression of
the mitochondrial encoded subunits (McEwen et al., 1986;
Tzagoloff and Dieckmann, 1990; Barrientos et al., 2002a; Solans
et al., 2004).
In Saccharomyces cerevisiae, translation of each mitochon-
drial COX mRNA depends on one or more translational
activator (for review, see Towpik, 2005). These mRNA-spe-
cific translational factors are either integral or peripheral
inner membrane proteins that recognize the 5-untranslated
region (UTR) of their target transcripts. Current speculations
suggest that translational activators may couple translation
to cotranslational insertion of the newly synthesized hydro-
phobic products into the membrane near or at the site of
their assembly into multisubunit complexes (Michaelis et al.,
1991; Naithani et al., 2003). Most activators, Mss51p being an
exception, interact with each other (Brown et al., 1994;
Naithani et al., 2003), suggesting some level of coregulation
in the expression of the core-forming subunits of COX (Fiori
et al., 2005). Interactions have also been noted between the
transcription factor Nam1p and translational activators, in-
cluding Pet111p, Pet309p, and Pet494p (Naithani et al., 2003;
Krause et al., 2004) raising the possibility that mitochondrial
transcription may be coupled to translation.
COX1 is the mitochondrial gene for subunit1/Cox1p, an
important catalytic subunit of COX containing copper and
heme A prosthetic groups. Translation of COX1 in S. cerevi-
siae is under the control of the MSS51 and PET309 gene
products that are also involved in maturation of the COX1
mRNAs (Decoster et al., 1990; Manthey and McEwen, 1995).
Mutations in MSS51 or overexpression of the wild type gene
can suppress shy1 null mutants by enhancing synthesis of
Cox1p (Barrientos et al., 2002b). The function of Shy1p in
maturation and/or assembly of Cox1p (Barrientos et al.,
2002b; Perez-Martinez et al., 2003; Smith et al., 2005) is of
considerable interest because mutations in its human homo-
logue, Surf1p, are responsible for most diagnosed cases of
Leigh’s syndrome presenting a COX deficiency (Tiranti et al.,
1998; Zhu et al., 1998).
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Cox1p synthesis is suppressed in most COX assembly
mutants, including shy1 mutants, but it is restored to normal
levels by mss51 suppressors of shy1 or by mutations in
COX14 (Barrientos et al., 2004), which codes for a COX
assembly factor (Glerum et al., 1995). Like other translational
activators Mss51p acts on the 5-UTR to initiate translation
(Perez-Martinez et al., 2003); however, mss51 mutants, unlike
pet309 mutants, cannot be suppressed by changes in the 5-
UTR of COX1 mRNA. (Perez-Martinez et al., 2003; Barrientos et
al., 2004). In addition, Mss51p acts on a target in the protein
coding sequence of COX1 mRNA to promote elongation
(Perez-Martinez et al., 2003). Mss51p and Cox1p form a
transient complex (Perez-Martinez et al., 2003; Barrientos et
al., 2004) that is stabilized by Cox14p (Barrientos et al., 2004).
These interactions have been postulated to down-regulate
Cox1p synthesis when COX assembly is impaired (Barrientos
et al., 2004). According to this model, the release of Mss51p
from the ternary complex and its availability for Cox1p
synthesis occur at a downstream step in the assembly path-
way, most likely catalyzed by Shy1p (Barrientos et al., 2004).
Further studies are necessary to clarify the functional signif-
icance of the interactions of Mss51p on the 5-UTR and the
coding sequence of COX1 mRNA.
In the present study, we report a novel mitochondrial
translation product, named mp15, with an apparent mass of
15 kDa. This protein is detected in mss51 null mutants
blocked in Cox1p synthesis and in strains carrying null
alleles in nuclear genes coding for COX subunits or assem-
bly factors in which the synthesis of Cox1p is reduced to 10%
or less of wild type. We present evidence that mp15 is a
truncated translation product of a partially unprocessed
COX1 mRNA and that it is synthesized by an Mss51p- but
not Pet309-independent mechanism. We also present evi-
dence that binding of Mss51p to the 5-UTR of COX1 mRNA
is necessary for optimal initiation of translation by Pet309p,
whereas the interaction of Mss51p with newly synthesized
Cox1p may regulate elongation of the nascent polypeptide.
MATERIALS AND METHODS
Strains and Media
The genotypes and sources of the S. cerevisiae strains carrying null alleles of
COX-related genes are listed in Table 1. Double mutants were constructed by
crosses of the single mutants. The compositions of the growth media have
been described previously (Myers et al., 1985).
In Vivo Mitochondrial Protein Synthesis
Mitochondrial gene products were labeled with [35S]methionine (7 mCi/
mmol; GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) in
whole cells at 30°C in the presence of cycloheximide (Barrientos et al., 2002b).
Equivalent amounts of total cellular proteins were separated by SDS-PAGE
on a 17.5% polyacrylamide gel, transferred to a nitrocellulose membrane, and
exposed to a Kodak X-OMAT x-ray film. Deviations from this procedure are
described in some figure legends.
Construction of COX Mutant Strains Carrying a
Proteolytically Inactive Version of yta10
The haploid strain W303yta10/Yta10E559Q (Table 1) was obtained from Prof.
T. Langer (Institut für Genetik und Zentrum für Molekulare Medizin, Uni-
versität zu Köln, Köln, Germany). This strain was crossed to a W303shy1
strain and to W303cox11. Diploid cells were sporulated and haploid progeny
with the two parental mutant alleles (yta10  shy1 or yta10  cox11) and the
yta10E559Q allele were isolated.
Protein Purification and Sequencing
Mss51p fused with the 26-kDa glutathione S-transferase (GST) was expressed
from an integrative plasmid (pG96/ST13) in a strain carrying a null mutant
allele of mss51 as reported previously (aW303mss51/ST13) (Barrientos et al.,
2004). This strain was respiratory competent and grew on nonfermentable
carbon sources with a doubling time similar to the parental wild type strain
(Barrientos et al., 2004). Mitochondria were prepared from aW303mss51/
ST13 strain by the method of Faye et al. (1974) except that zymolyase 20,000
(ICN Biochemicals, Aurora, OH) instead of glusulase was used to digest the
cell wall. Mitochondrial proteins (5 mg) were solubilized with 1% lauryl
maltoside in the presence of 0.5 M KCl and 1 mM phenylmethylsulfonyl
fluoride. The extract was clarified by centrifugation at 50,000  gav for 30 min
and incubated with glutathione-Sepharose beads for 4 h at 4°C. After centrif-
ugation at 1500 rpm for 5 min, the beads were washed three times with
phosphate-buffered saline. The Mss51p–GST fusion protein was eluted with
10 mM glutathione, 50 mM Tris-base, pH 8.0, and concentrated using
Vivaspin 500 columns. The concentrate was separated in a 12% SDS-PAGE
system, transferred to a polyvinylidene fluoride membrane and stained with
Coomassie blue. A prominent band of 68 kDa was excised from the mem-
brane and used to sequence the N-terminal seven residues with a Procise
Sequencer (Applied Biosystems, Foster City, CA) in the Proteomics facility of
the University of Miami.
Yeast Three-Hybrid System (Y3H)
A Y3H system to map the interacting domain in Mss51p and its target in the
5-UTR of COX1 mRNA was developed by using the commercially available
RNA-Protein Hybrid Hunter kit (Invitrogen, Carlsbad, CA). Portions of the
COX1 mRNA 5-UTR were cloned into the plasmid pRH3 and portions, of
Mss51p were expressed from the plasmid pYESTrp2. The host strain L40-ura-
ms2 was cotransformed with pairs of pRH3/and pYESTrp2/constructs, and
the transformants were selected on yeast synthetic medium missing the
appropriate auxotrophic markers (Ura and Trp) and histidine. The His-
deficient medium selected for expression of the HIS3 reporter gene, e.g., for
colonies in which the RNA–protein interaction was produced. Inclusion of 5
mM 3-minotriazole, a competitive inhibitor of the HIS3 reporter protein,
suppressed background growth in the His medium. Cotransformations of
the host strain with pair-combinations of the parent plasmids and one of the
constructs served as controls. Interactions were confirmed by assaying for
-galactoside, the second reporter using a filter lift assay as described previ-
ously (Breeden and Nasmyth, 1985).
Miscellaneous Procedures
Standard procedures were used for the preparation and ligation of DNA
fragments and for transformation and recovery of plasmid DNA from Esch-
erichia coli (Sambrook et al., 1989). Yeast were transformed by the method of
Schiestl and Gietz (1989). The one-step gene insertion method (Rothstein,
1983) was used to integrate linear plasmids at the URA3 or LEU2 locus of
yeast nuclear DNA. Mitochondrial RNA was prepared from isolated mito-
chondria by modified extraction with hot-acidic phenol (Ausubel et al., 1994).
RESULTS
Synthesis of a Novel Polypeptide from a COX1 Transcript
in mss51 Null Mutants
PET309 and MSS51 code for inner membrane proteins that
are essential for translation of mitochondrial COX1 mRNA
in S. cerevisiae (Decoster et al., 1990; Manthey and McEwen,
1995). In agreement with earlier studies, mutations in either
of these genes abolish synthesis of Cox1p (Figure 1A). How-
ever, a new low-molecular-weight polypeptide with a mi-
gration intermediate between Atp6p and Atp8p in SDS-
PAGE was detected among the mitochondrial translation
products labeled with [35S]methionine in the mss51 null
mutant. Expression of wild-type MSS51 from integrative
and episomal plasmids in this mss51 null mutant strain
completely restored its ability of synthesizing Cox1p and
abolished the synthesis of the new polypeptide (data not
shown). This protein was absent in the pet309 mutant and in
a pet309/mss51 double mutant (Figure 1A). The absence of
the novel polypeptide in the pet309 mutant suggested that it
could be a truncated product of COX1 requiring Pet309p for
initiation of translation but destined for premature termina-
tion in the absence of Mss51p. To further establish the origin
of the new polypeptide, mtDNA of M5-16/A3, a mutant
with a large deletion in COX1 (Tzagoloff et al., 1975) was
transferred by cytoduction to an mss51 null mutant and its
parental wild type, both lacking mtDNA (o strains). No
synthesis of Cox1p or the novel protein was seen in the cox1
mutant either in the presence or absence of the mss51 null
mutation (Figure 1B). These data constitute strong evidence
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Table 1. Genotypes and sources of yeast strains
Strain
Strains with mitochondrial DNA of different source and intron composition
Genotype mtDNA Source
W303-1A MATa ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1  bI, aI1, aI2,
aI3, aI5
R. Rothstein (Department of
Human Genetics, Columbia
University, New York, NY)
W303-1B MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1  bI, aI1, aI2,
aI3, aI5
R. Rothstein
W303/0 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 o This study
D273-10B/A1 MATa met6  bI, aI1,
aI2, aI3,
aI4, aI5g
Tzagoloff et al. (1976)
JC3/o MATa kar1-1 ade2 lys2 o ATCC 201577
JC3/D273 MATa kar1-1 ade2 lys2  bI, aI1,
aI2, aI3,
aI4, aI5g
JC3 o  D273-10B/A21
JC11/rCK5112 MAT, kar1-1, his3  aI2, aI3,
aI5 w
J. Lazowska (Centre de
Génétique Moleculaire du
Centre National de la
Recherche Scientifique,
Gif-sur-Yvette, France)
JC11/rWI04 MAT, kar1-1, his3  bI, aI1, aI2,
aI3, aI5 
Labouesse (1990)
JC3/rGF134-6D MATa kar1-1 ade2 lys2  bI, aI4 Barros et al. (2006)
D273-10B/G1-224 MAT met6  bI, aI1, aI2,
aI3, aI4
Seraphin et al. (1987)
JC3/G1-224 MATa kar1-1 ade2 lys2  bI, aI1, aI2,
aI3, aI4
JC3o  D273-10B/G1-224
D273-10B/G1-356-R5 MAT met6 lys2  bI, aI1, aI4,
aI5g
Seraphin et al. (1987)
JC3/G1-356-R5 MATa kar1-1 ade2 lys2  bI, aI1, aI4,
aI5g
JC3o  D273-10B/G1-356-R5
aW303/Io MATa ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1  Io Barros et al. (2005)
JC3/W303 MATa kar1-1 ade2 lys2  bI, aI1, aI2,
aI3, aI5
JC3o  W303-1B






mss51/G1-224 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
mss51::HIS3
 bI, aI1, aI2,
aI3, aI4
W303mss51  JC3/ G1-224
mss51/G1-356-R5 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
mss51::HIS3
 bI, aI1, aI4,
aI5g
W303mss51  JC3/G1-356-R5





mss51/GF134-6D MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
mss51::HIS3
 bI, aI4 W303mss51  JC3/GF134-6D
mss51/WI04 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
mss51::HIS3
 bI, aI1, aI2,
aI3, aI5
W303mss51  JC11/WI04
mss51/Io MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
mss51::HIS3
 Io W303mss51  W303/Io
shy1/ G1-224 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
shy1::URA3
 bI, aI1, aI2,
aI3, aI4
W303mss51  JC3/G1-224
shy1/G1-356-R5 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
shy1::URA3
 bI, aI1, aI4,
aI5g
W303mss51  JC3/G1-356-R5





shy1/GF134-6D MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
shy1::URA3
 Bi, aI4 W303 mss51  JC3/GF134-6D
shy1/Io MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1
shy1::URA3
 I° W303 mss51  JC3/Io
Structural subunitsb
W303cox4 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox4::URA3 W303 Glerum and Tzagoloff (1997)
W303cox5a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox5a::HIS3 W303 Glerum and Tzagoloff (1997)
W303cox6 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox6::URA3 W303 Glerum and Tzagoloff (1997)
W303cox7 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox7::URA3 W303 Barrientos et al. (2004)
W303cox9 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox9::URA3 W303 Barrientos et al. (2004)
M5-16-A3 ade1 cox1 D273 Tzagoloff et al. (1975)
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Table 1. Continued
Straina
Strains with mutant alleles of cox assembly factors
Genotype mtDNA Source
COX1 expressionb
W303pet309 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 pet309::HIS3 W303 Glerum and Tzagoloff (1997)
W303mss51 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 mss51::HIS3 W303 Barrientos et al. (2002b)
C199 met6 mss51-199 D273 Tzagoloff, unpublished data
C283 met6 mss51-283 D273 Tzagoloff, unpublished data
Maturation of CuA
or CuB centersb
W303cox17 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox17::TRP1 W303 Glerum et al. (1996a)
W303sco1 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 sco1::URA3 W303 Glerum et al. (1996b)
W303cox11 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox11::HIS3 W303 Tzagoloff et al. (1990)
COX2 expressionb
W303oxa1 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 oxa1::HIS3 W303 Hell et al. (2000)
W303cox18 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox18::URA3 W303 Souza et al. (2000)
W303pet111 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 pet111::HIS3 W303 Barros et al. (2002)
W303imp1 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 imp1::HIS3 W303 Barrientos et al. (2004)
W303imp2 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 imp2::URA3 W303 Barros et al. (2002)
Heme biosynthesisb
W303cox10 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox10::HIS3 W303 Nobrega et al. (1990)
W303cox15 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox15::HIS3 W303 Glerum et al. (1997)
Assembly/unknownb
W303pet117 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 pet117::HIS3 W303 Barros et al. (2002)
W303shy1/U2 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 shy1::URA3 W303 Barrientos et al. (2002b)
W303pet191 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 pet191::HIS3 W303 Barrientos et al. (2004)
W303cox14 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox14::TRP1 W303 Barrientos et al. (2004)
W303cox16 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox14::URA3 W303 Carlson et al. (2003)
W303cox19 ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 cox19::URA3 W303 Nobrega et al. (2002)
Strains carrying mutant alleles of yta10
YHA103 MATa ade2-1 his3-11,15 trp1-1 leu2,112 YCplac111
(LEU2, CEN):ADH1-YTA10E559Q ura3-52
yta10::URA3
W303 Arlt et al. (1996)
W303shy1yta10/
yta10E559Q
MATa ade2-1 his3-11,15 trp1-1 leu2,112 YCplac111
(LEU2, CEN):ADH1-YTA10E559Q ura3-52
yta10shy1::URA3
W303 W303shy1  YHA103
W303cox11yta10/
yta10E559Q
MATa ade2-1 his3-11,15 trp1-1 leu2,112 YCplac111
(LEU2, CEN):ADH1-YTA10E559Q ura3-52
yta10::URA3 cox11::HIS3
W303 W303cox11  YHA103
a All null mutations have been created or are available in both a and  mating types.
b These headings indicate the functional category of the deleted gene products.
Figure 1. Pet309p and COX1-dependent
synthesis of a novel protein in mss51 null mu-
tants. (A) In vivo synthesis of mp15 by mss51
mutants requires the presence of Pet309p. Mi-
tochondrial products of wild type (W303) and
of pet309 and mss51 single or double mutants
were labeled with [35S]methionine at 30°C
for 10 min in the presence of cycloheximide
(Barrientos et al., 2002b). (B) A partial deletion
of COX1 blocks in vivo synthesis of mp15.
Mitochondrial products were labeled as in A
in the wild type W303-1A (W303) and mss51
null mutants (mss51) in different mitochon-
drial genetic backgrounds: W303-mtDNA (W303),
D273-mtDNA (W303D273), mss51D273), or
cox1-mtDNA (Tzagoloff et al., 1975), the later
a D273 type of D273-mtDNA with a partial
deletion of the COX1 gene obtained from
strain M5.16-A3 (Table 1). mss51rDcox1 -1 and
-2 and mss51D273 -1 and -2 are two different
cytoductants of each type.
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that the novel protein, which we have named mp15, is
encoded by a COX1 transcript.
The mtDNA of D273-10B, the parent of the cox1 mutant
M5-16/A3 was also transferred to the mss51 mutant and to the
isogenic wild-type strain W303-1A. The introduction of the
D273 mtDNA into the W303 nuclear background of the mss51
mutant resulted in significantly reduced synthesis and/or sta-
bility of mp15 (Figure 1B). No mp15 was detected in the pa-
rental strain with wild-type MSS51 and D273-10B mtDNA.
The mp15 detected in mss51 mutants could be a novel
translation product of a COX1 transcript or a degradation
product of Cox1p. The fact that no Cox1p is detected in
mss51 mutants, even after pulses of up to 60 min (data not
shown), suggested that there is no synthesis of full-length
Cox1p. Detection of mp15 after a 2.5-min pulse, the shortest
time needed to observe a clear pattern of labeled proteins in
the in vivo experiments (data not shown), argues against
degradation of Cox1p as the source of mp15.
Radiolabeled mp15 separated by SDS-PAGE migrates
slightly above 14-kDa marker (Figure 2) indicating a molec-
ular weight of 15,000. Because hydrophobic proteins do
not always separate true to size, the actual molecular weight
could be larger.
Because mp15 is synthesized in low amounts, only de-
tected because it is radiolabeled, and is highly labile (ex-
plained below), it is very difficult to purify enough protein to
attempt mass spectrometry characterization. Attempts will
be made in the future with this goal.
Pet309-dependent Synthesis of mp15 Polypeptide Occurs
in COX Assembly-arrested Mutants Displaying Reduced
Synthesis of Cox1p
Mss51p was proposed to play a role in adjusting translation
of Cox1p to the availability of its partners subunits during
assembly of COX (Barrientos et al., 2002b, 2004). This was
based on observations that synthesis of Cox1p is greatly
reduced in most COX assembly mutants (Barrientos et al.,
2004; Figure 3, A and B). The small amount of Cox1p de-
tected in such mutants may reflect the fraction of this sub-
unit that is associated with and stabilized by Mss51p and
Cox14p (Perez-Martinez et al., 2003; Barrientos et al., 2004).
Assembly-defective mutants in which Mss51p is tied up with
unassembled Cox1p would be expected to have substantially
reduced amounts of Mss51p available for new rounds of
Cox1p translation, thereby allowing synthesis of mp15.
In vivo labeling of mitochondrial gene products indicated
that with the exception of the cox14 mutant, all the other
COX mutants tested synthesize mp15 (Figure 3A). As with
the mss51 mutant, the presence of a second mutation in
pet309 completely suppressed the synthesis of mp15 in all
the COX mutants (Figure 3A). The efficiency of mp15 syn-
thesis was variable but never as high as in the mss51 mutant.
No mp15 was detected in the cox14 mutant, which as reported
previously, synthesizes normal amounts of Cox1p (Barrientos
et al., 2004; Figure 3, A and B). Synthesis of mp15 was also
abolished or greatly reduced in double mutants in which a null
allele in a COX assembly gene was combined with a deletion of
COX14 (Figure 3B). Such strains were previously shown to
synthesize Cox1p normally (Barrientos et al., 2004).
Synthesis of mp15 in the mss51 Mutant Is Not Affected by
a cox14 Mutation
Cox14p plays an important role in regulating translation of
COX1 mRNA. In other studies, we have shown that cox14
mutants synthesize normal amounts of Cox1p. Moreover,
the cox14 mutation cures the Cox1p translational defect of
most COX mutants (Barrientos et al., 2004). This was inter-
preted to indicate that Cox14p may be necessary to stabilize
the interaction of Mss51p with Cox1p. Accordingly, mutants
lacking Cox14p would have more Mss51p available for
translation of Cox1p.
The synthesis of mp15 is independent of Cox14p, because
incorporation of [35S]methionine into mp15 was the same in
the mss51 single mutant and in a strain with mutation in
both mss51 and cox14 (Figure 4A). Overexpression of COX14
from the episomal plasmid pG93/T1 (Glerum et al., 1995) in
a mss51 null mutant strain also did not influence the synthe-
sis of mp15. These results support a role of Cox14p in
regulating the availability of Mss51p for translation by trap-
ping the protein in a ternary complex with full-length
Cox1p, rather than acting to inhibit translational elongation.
Accumulation of mp15 Is Significantly Reduced In Vivo in
COX Assembly Mutants Pretreated with Chloramphenicol
We have previously shown that, with the exception of the
mss51, pet309, and oxa1 mutants, Cox1p labeling was in-
creased in COX mutants when cells were preincubated in
chloramphenicol (CAP) before the in vivo pulse (Barrientos
et al., 2004), which was interpreted to be due to the accumu-
lated larger pools of nuclear-encoded factors (i.e., Mss51p)
required for mitochondrial gene expression. We wanted to
test now if the enhanced synthesis of Cox1p in most COX
assembly mutants had a modifying effect on the amount of
newly synthesized mp15.
We first tested the effect of CAP preincubation on mp15
synthesis in mss51 mutants. Incorporation of [35S]methi-
onine into mp15 in an mss51 null mutant strain was substan-
tially lower in CAP-pretreated cells (Figure 5, A and B).
Although at variable levels, in some experiments, the
amount of newly synthesized mitochondrial ribosomal pro-
tein Var1 was also reduced in mss51 mutants pretreated with
CAP, suggesting an effect of the antibiotic on ribosome
metabolism that could be also related to the reduced syn-
thesis of mp15. However, the amount of newly synthesized
mp15 was consistently reduced in CAP-pretreated mss51
mutant cells even in experiments in which the amount of
newly synthesized Var1 was not affected. The reduction in
mp15 was unlikely to be due to faster turnover, because it was
observed at the shortest times of labeling. Pulse-chase experi-
ments also showed that mp15 synthesized in 10 min (Figure 5,
Figure 2. Electrophoretic mobility of mp15. Mitochondrial prod-
ucts were labeled in vivo in a wild type (W303-1A) and a mutant
strain carrying a null allele of mss51 (mss51) as in Figure 1. Total
cellular proteins were separated in a 17.5% PAGE (Barrientos et al.,
2002b). Cox1p of the wild-type cells and mp15 from the mss51
mutant were excised from the SDS polyacrylamide gel and electro-
eluted using ElutaTube Protein Extraction kit (Fermentas, Ontario,
Canada). The proteins were trichloroacetic acid (TCA) precipitated
and resuspended in loading buffer. The radiochemical purity of the
two proteins was tested by separation on a second 12% polyacryl-
amide gel (Laemmli, 1970) or a 20% polyacrylamide gel in Tris-
Tricine buffer (Schagger and von Jagow, 1987).
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B and C) or 15 min of pulse (data not shown) with or without
the CAP pretreatment were degraded at similar rates.
Pretreatment with CAP of different COX assembly-defec-
tive mutants reduced incorporation of [35S]methionine into
mp15 to undetectable levels (Figure 5D). Synthesis of Cox1p
in the CAP-treated mutants was comparable with that seen
in wild type under normal pulse-labeling conditions. This
confirms the presence of a fully functional translation appa-
ratus in the COX mutants and supports the earlier conclu-
sion that synthesis of Cox1p is down-regulated in such
strains (Barrientos et al., 2004).
Mp15 Is a Membrane Protein and the Yta10p/Yta12p
Protease Is Partially Responsible for Its Degradation
Cox1p is an integral protein, embedded in the mitochondrial
inner membrane with 12 transmembrane -helices (Tsukihara
et al., 1996). To test whether mp15 is also a membrane-bound
protein, we have determined its solubility properties. Sonic
irradiation of mss51 spheroplasts containing newly synthe-
sized 35S-labeled mitochondrial translation products solubi-
lized -ketoglutarate dehydrogenase, a soluble protein of
the mitochondrial matrix, but not mp15 nor any of the other
newly synthesized proteins that are known to be cotransla-
tionally inserted in the membrane (Figure 6A). These results
suggest that also mp15 is cotranslationally inserted in the
mitochondrial inner membrane.
Our failure to detect mp15 with monoclonal antibodies
against Cox1p (data not shown) suggested that either the
Cox1p epitope is not present in mp15 or/and that most of
this protein is degraded. Pulse-chase analysis of mp15 sta-
bility in an mss51 null mutant indicated 50% of the newly
synthesized mp15 to be degraded after a 1-h chase (Figure
6B). The stability of unassembled Cox1p and of mp15 was
Figure 3. Accumulates of mp15 in vivo in
COX assembly-arrested mutants. (A) Wild
type (W303-1A), mss51, cox14, cox16, cox18,
sco1, cox7, and cox17 single null mutants or
double mutants with a second null mutation
in PET309 were labeled with [35S]methionine
at 30°C for 15 min in the presence of cyclohex-
imide as in Figure 1. (B) Wild type (W303-1A),
cox14 single mutant or double mutants with a
second mutation in shy1, cox15, and sco1 were
labeled with [35S]methionine at 30°C for 15
min in the presence of cycloheximide as in
Figure 1. The mitochondrial translation prod-
ucts are identified in the margin. The func-
tions affected in the different strains are de-
scribed in Table 1.
Figure 4. COX14 does not affect synthesis and accumulation of
mp15. (A) Wild type (W303-1A), an mss51 null mutant, and an
mss5/cox14 double mutant were labeled with [35S]methionine at
30°C for 15 min in the presence of cycloheximide as described in
Figure 1. (B) Wild type (W303-1A), and a null mutant of mss51
overexpressing or not COX14, were labeled in vivo as described in
A. The mitochondrial translation products are identified in the
margin.
A. Zambrano et al.
Molecular Biology of the Cell528
also assessed in different COX mutants. In agreement with
our previous findings, the small amount of labeled Cox1p
present in the mutants was stable for at least 2 h of chase
(Barrientos et al., 2004; Figure 6C). In contrast, mp15 was
almost completely degraded after the 2-h chase.
Turnover of mitochondrially synthesized COX subunits
that do not enter the assembly pathway is a function of
different proteases, including the m-AAA protease complex
Yta10p/Yta12p (Arlt et al., 1996), which also acts as a chap-
erone for assembly of the mitochondrial respiratory chain
complexes (Arlt et al., 1996). The protease function can be
inactivated by the E559Q mutation in the active site of
Yta10p without affecting the chaperone function of the com-
plex (Arlt et al., 1996). The role of the Yta10p/Yta12p in
turnover of mp15 was studied in shy1/yta10 and a cox11/
yta10 double mutant harboring the yta10E559Q allele. In vivo
pulse-chase experiments of the double mutants revealed
that mp15 is a substrate of Yta10p/Yta12p protease as a
considerable amount of this novel protein was spared from
degradation during the 1–2 h of chase in the background of
the yta10E559Q allele (Figure 6C).
Synthesis of mp15 Is Affected by the Intron Composition
of COX1
W303mss51, an mss51 null mutant containing W303
mtDNA, had significantly more mp15 than the same mutant
with D273 mtDNA (Figure 1). The only significant difference
in the COX1 genes of the two strains is the presence of
additional introns in the gene of D273 mtDNA (Figure 7). In
the absence of Mss51p, splicing of COX1 pre-mRNA con-
taining a particular combination of introns may result in the
accumulation of a particular splicing intermediate that serves
as an mRNA for the aberrant mp15 translation product.
To further ascertain the intron requirement for mp15 syn-
thesis, mtDNA with different intron-containing COX1 genes
(Figure 7) were transferred to o derivatives of mss51 and
shy1 null mutants. In vivo labeling of the mitochondrial
products in the resultant strains showed that mp15 was
detected as a prominent band in strains containing the mi-
tochondrial genome of W303 but not D273 (Figure 1B). To
confirm that the efficient production of mp15 was related to
its COX1 gene, mtDNA from Wi04, a strain with the same
COX1 introns as W303, was also transferred to the mss51 and
shy1 null mutants. Synthesis of mp15 in both mutants was
comparable with that seen in the same strains with the W303
mtDNA (data not shown). Based on the in vivo labeling
results obtained with other mss51 mutants harboring differ-
ent COX1 genes, however, it was not possible to relate the
synthesis of mp15 to the absence of a particular intron,
although the presence of aI1 and 5 seems to be an absolute
requirement (Figure 7).
Figure 5. Synthesis and/or accumulation of
mp15 are reduced in COX assembly mutants
pretreated with chloramphenicol. (A) Effect of
CAP pretreatment on in vivo labeling of mi-
tochondrial gene products. Wild type (W303-
1A) and the mss1 null mutant (mss51) were
grown in YPGal. One-half of the cultures were
further incubated at 30°C for 2 h in the pres-
ence of 2 mg/ml CAP. Cells were harvested
and washed two times with a solution con-
taining 40 mM potassium phosphate plus 2%
galactose before labeling. Samples were re-
moved after the indicated times of labeling
and processed as in Figure 1. (B) Degradation
of mp15 synthesized in cells pretreated or not
with CAP. The mss1 null mutant (mss51) was
incubated in the presence and absence of CAP
as described in A. After harvesting and wash-
ing, cells were pulsed with [35S]methionine for
10 min. Labeling was terminated by addition
of 80 mol of cold methionine and 12 g/ml
puromycin (0 time). Samples of the cultures
were collected after the indicated times of in-
cubation at 30°C and processed as described
in Figure 1. (C) Quantification of mp15 degra-
dation in B. The radiolabeled bands were de-
tected and quantified with a PhosphorImager
(GE Healthcare). The values (arbitrary units)
were plotted against the time of chase. (D)
Effect of CAP pretreatment on the mitochon-
drial protein synthesis pattern of cox10, imp1,
and cox7 null mutants. Cells were labeled as in
A. Mitochondrial translation products are
identified in the margin. Cox2p is not pro-
cessed in imp1 mutant. The Cox2p precursor
(pCox2p) in these strain migrates slower that
the mature Cox2p (mCox2p). The functions
affected in the different mutants are described
in Table 1.
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No synthesis of mp15 was seen in C199, a strain with D273
mtDNA and a point mutation in mss51 causing partial loss
of function (data not shown). This was also true of five other
mss51 point mutants in the same mitochondrial genetic
background (data not shown). Substitution of D273 by W303
mtDNA in C199, however, allowed some limited synthesis
of mp15. These results could suggest that expression of
mp15 is at least partially dependent on the nuclear back-
ground or that the synthesis of mp15 is reduced in leaky
mutants of mss51.
mp15 Is Translated from a Partially Processed COX1
Transcript
Synthesis of mp15 occurs in strains lacking Mss51p but not
Pet309p, and additionally, it requires a COX1 gene with a
particular set of introns. Because processing and translation
of COX1 transcripts are interdependent events, splicing of
some COX1 introns being dependent on translation of in-
tron-encoded maturases (Carignani et al., 1983, 1986), mp15
is likely to be derived from an incompletely processed COX1
transcript. It was not excluded, however, that mp15 might
be translated from an aberrantly spliced or partially de-
graded COX1 transcript. To rule out these possibilities, we
examined the COX1 transcripts by Northern blot analysis of
total mitochondrial RNAs of mss51, pet309, and shy1 mutants
(Figure 8). Even though the amount of mature COX1 mRNA
was reduced in the mss51 mutant, as reported previously
(Simon and Faye, 1984), the exon A5/intron aI5 probe re-
vealed a similar pattern of COX1 precursors in the mss51 and
shy1 mutants (Figure 8A). No new small mRNA species
were found in either strain (Figure 8A). The probe against
the entire coding sequence of COX1, confirmed the presence
both mature and partially processed transcripts in the mss51
mutant with a COX1 gene containing four or more introns
(W303) (Figure 8B). In agreement with previous reports,
neither mature nor precursor COX1 RNAs were present in
the pet309 mutant because of their instability in this genetic
background (Manthey and McEwen, 1995). Mature COX1
mRNA was also detected in two point mutants of mss51 in
the D273 background, C199 and C283 (data not shown).
The presence of mature COX1 mRNA in the mss51 mutant
suggests that there is sufficient translation of intron-encoded
maturases for splicing of introns aI1, -2, and -3, although the
possibility of enhanced self-splicing in the absence of
Mss51p cannot be eliminated. As expected, normal levels of
COX1 mRNA are present in the mss51 mutant with intron-
less mtDNA. The absence in this strain of mp15 also sup-
ports the notion that it is likely to be a translation product of
a partially spliced COX1 transcript.
Mss51p Binds to the 5-UTR of COX1 mRNA
Mss51p has been conjectured to act on the COXI mRNA
5-UTR to initiate translation and on the coding sequence to
promote elongation (Decoster et al., 1990; Perez-Martinez et
al., 2003). Because mp15 is only detected in the W303 and
D273 mtDNA backgrounds, it is conceivable that the pres-
ence of a particular sequence(s) in the 5-UTR of COX1 of
these strains could by-pass the requirement of Mss51p for
translation initiation but not elongation. Under these cir-
cumstances, synthesis of Cox1p could be prematurely ter-
minated.
The putative interaction/s of Mss51p with the 5-UTR of
COX1 mRNA has not been characterized. We have used the
Y3H depicted in Figure 9A to define both the RNA target(s)
sequence and the Mss51p domain involved in the binding to
the RNA. The constructs used as baits consisted of 460 base
pairs 5-UTR sequence (Manthey and McEwen, 1995) as well
as different regions of the 5-UTR with part of the first exon
Figure 6. mp15 is a membrane protein whose degradation de-
pends partially on a proteolytically active YTA10/YTA12 complex.
(A) mp15 is a membrane protein. Wild type (W303-1A) and a
mutant carrying a null allele of mss51 were grown and labeled for 15
min at 30°C with [35S]methionine in the presence of cycloheximide.
Cells were subsequently converted to spheroplasts by digestion of
the cell wall with zymolyase and submitted to sonic radiation.
Samples were centrifuged 25,000 rpm, and the pellet (P) and super-
natant (S) fractions were collected, TCA precipitated, and resus-
pended in loading buffer. The proteins were separated into a 17.5%
PAGE and transferred to a nitrocellulose membrane. The membrane
was both, exposed to x-ray film (bottom) and used for a Western
blot that was probed with a polyclonal antibody against the matrix
soluble protein -ketoglutarate dehydrogenase (top). (B) mp15 is
rapidly degraded after synthesis. Wild type (W303-1A) and a mu-
tant carrying a null allele of mss51 were grown and labeled for 15
min at 30°C with [35S]methionine. Labeling was terminated by
addition of 80 mol of cold methionine and 12 g/ml puromycin (0
time). Samples of the cultures were collected after the indicated
times of incubation at 30°C and processed as in Figure 1. (C)
Degradation of mp15 is partially mediated by the YTA10/YTA12
complex. The wild type strain W303-1A, the shy1, and cox11 mu-
tants, and the same mutants in which the endogenous wild-type
YTA10 gene had been substituted by the catalytically inactive
yta10E559Q mutant gene (Arlt et al., 1996) were labeled and chased for
the indicated times as in A. Mitochondrial translation products are
identified in the margin.
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Figure 7. Synthesis of mp15 depends on the
intron composition of the COX1 gene. The
figure represents the maps of COX1 in differ-
ent strains of yeast. Group II introns are cir-
cled. mtDNA containing COX1 genes with
different intron compositions (see details in
Table 1) were transferred by cytoduction into
to a kar1 mutant (Conde and Fink, 1976) de-
void of mtDNA (o). The different mitochon-
drial genomes were transferred from the kar1
donor to o derivatives of mss51 and shy1 null
mutants. To determine whether mp15 was
synthesized in these strains, the mitochondrial
gene products of the corresponding strains
were labeled in vivo in the presence of cyclo-
heximide and separated on a 17.5% polyacryl-
amide gel as in Figure 1. The last two columns
on the right represent a summary of the re-
sults obtained.
Figure 8. Mature and unprocessed COX1
transcripts accumulate in mss51 and shy1 but
not in pet309 null mutants. (A) Mitochondrial
RNA was extracted from mitochondria puri-
fied of the wild-type strain W303-1A, a shy1
null mutant (shy1), an mss51 null mutant
(mss51) and a double shy/1mss51 mutant
(shy1 mss51). The RNA extracts were sep-
arated onto a 1% agarose gel, stained with
ethidium bromide, photographed, and the
RNAs blotted to a nylon membrane (Nytran,
SuPerCharge; Whatman Schleicher and Schuell,
Keene, NH). After cross-linking with UV
light, the nylon membrane was prehybridized
at 43°C with 125 g of salmon sperm DNA in
5 SSC, 5 Denhardts, 0.5% SDS. The blotted
RNAs were hybridized overnight at 43°C
with probes containing exon 5  intron 5 of
COX1 and exon 1 of COB. Both probes were
labeled with [-32P]dATP by random priming
(Feinberg and Vogelstein, 1983). (B) Mito-
chondrial RNA extracts were separated onto a
denaturing 1.2% agarose gel, blotted to a ny-
lon membrane and UV-light cross-linked.
Northern blots of mitochondrial RNA of the
wild-type W303-1A, the mss51, pet309, and
shy1 null mutants with a W303 mtDNA back-
ground (Figure 7A) and the mss51 null mu-
tant with an intronless mitochondrial genome
were prehybridized at 42°C for 2 h with 1 g
of salmon sperm and hybridized overnight at
65°C in a solution containing 7% SDS, 1 M
EDTA, and 0.5 M Na2PO4 with probes con-
taining the entire coding sequence of COX1 or
COB. The mature (M) and unprocessed (P)
COX1 transcripts are identified in the margins.
The left panels in A–C shows the ethidium
bromide-stained gels used for the Northern
blots. The positions of the 15S and 21S mitochondrial rRNAs are indicated.
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of the COX1 gene (Figure 9B). To ensure targeting of the
Mss51p/Gal4 fusion proteins to the nucleus, a requirement
in the Y3H system, the mitochondrial leader peptide of
Mss51p was deleted. The mitochondrial import sequence of
Mss51p determined by protein sequencing of Mss51p-GST
purified from mitochondria consists of the N-terminal 35
residues encoded by the gene.
The results obtained with different COX1 and MSS51 con-
structs indicated an interaction between the MSS51-140 do-
main expressing the first 177 amino acids of the mature
protein and a sequence located between nucleotides 245
and 23 of COX1 mRNA (Figure 9C). This domain did not
interact with the MSS51-398 construct, which should pro-
duce the entire Mss51p (data not shown), perhaps because
folding of the membrane protein interferes with recognition
of the bait. No interaction was detected between MSS51-140
and COX1.1 (data not shown), suggesting that the interact-
ing mRNA domain is located between nucleotides 97 and
23, although we cannot exclude the possibility that the
longer COX1.1, as in COX1.2, made the mRNA bait unsuit-
able for the assay. The MSS51–140 sequence encodes a hy-
drophilic domain, which probably protrudes into the mito-
chondrial matrix where it interacts with the 5-UTR of COX1
mRNA.
The region of the 5-UTR of COX1 that was ascertained to
interact with Mss51p did not display any nucleotide varia-
tion in the mtDNAs of D273, W303, and the strain with the
intronless gene.
DISCUSSION
Mss51p is a mitochondrial inner membrane protein that
faces the matrix (Siep et al., 2000). Together with Pet309p, it
interacts with the 5-UTR of the COX1 mRNA to initiate
translation (Perez-Martinez et al., 2003). The yeast three-
hybrid experiments reported here suggest that the target in
the 5-UTR of COX1 mRNA could be within 245 nucleotides
upstream of the initiation codon. The sequence in Mss51p
that could interact with this activation site has been mapped
to a hydrophilic region located in the N-terminal 177 resi-
dues of the mature protein.
As noted previously, mss51 mutants lack Cox1p; unex-
pectedly, however, we found that they synthesize a novel
15-kDa protein. Several lines of evidence suggest that mp15
is translated from a COX1 transcript. This protein is not
present in pet309 mutants in which initiation of COX1 trans-
lation is blocked and which do not accumulate mature or
precursor COX1 mRNAs when this mitochondrial gene con-
tains more than four introns (Manthey and McEwen, 1995).
In addition, no mp15 is detected in an mss51/pet309 double
mutant or in a mutant with a large deletion in COX1.
Translation of a Cox1p-related protein in mss51 mutants is
at variance with previous observations that the interaction of
Mss51p with the 5-UTR of COX1 is essential for translation
of Cox1p. This was evident by the failure of an mss51 mutant
to express ARG8m when the recoded gene was substituted
for COX1 and was fused to the normal 5-UTR of COX1
(Perez-Martinez et al., 2003). The possibility that the require-
Figure 9. Mss51p binds to the 5-UTR of COX1 mRNA. (A) Y3H strategy used to explore the interaction of Mss51p with the 5-UTR of COX1
mRNA. (B) Diagram showing the regions of Mss51p (including a hydrophobicity map) and the COX1 mRNA that were used to make the Y3H
constructs. (C) A domain in the N-terminus of Mss51p (Mss51.140; marked with a square in the hydrophobicity map in B) interacts with a
domain in the 5-UTR of COX1 mRNA (Cox1.4; marked with an arrow in B). Activation of the -galactosidase reporter gene detected as a
blue color occurred only when both the protein prey and RNA bait were expressed.
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ment for Mss51p for translation is by-passed in mp15-pro-
ducing strains as a result of a polymorphism in the COX1
5-UTRs has been excluded as no sequence differences were
found in their Mss51p-interacting domain. These observa-
tions suggest that translation of mp15 is initiated from an
ATG other than the normal COX1 initiation codon. The
dependence of mp15 expression on Pet309p, a protein im-
plicated in translation initiation of COX1 mRNA (Manthey
and McEwen, 1995), may be related to the already men-
tioned absence of COX1 transcripts in pet309 mutants and
therefore does not exclude the use of an alternate start
codon. Whether translation of mp15 starts in an exon or
intron is unclear, although an exonic ATG is more likely for
several reasons. The partially overlapping peptide patterns
of Cox1p and mp15 indicate the presence in the latter of
some exon-encoded sequences. Because the reading frames
of COX1 introns are in register with the reading frames of
their upstream but not downstream exons, a 15-kDa product
could be expressed exclusively from an mRNA containing
intron sequences but not from a reading frame initiated in an
intron and encompassing the downstream exon.
Alternatively, mp15 could result from premature termi-
nation of translation of a COX1 transcript. Recent evidence
has shown that Mss51p acts on target/s within the coding
sequence of the COX1 mRNA or to the protein itself, to
promote translational elongation and that in the absence of
Mss51p, nascent Cox1p may block its own synthesis (Perez-
Martinez et al., 2003). Translational regulation by nascent
Figure 10. Model depicting the hypothetical roles of Mss51p in Cox1p translation and coupling to Shy1p-dependent COX assembly. Mss51p
is required for translation of Cox1p by acting, together with Pet309p on the 5-UTR of COX1 mRNA. As shown before (Barrientos et al., 2004),
Mss51p binds newly synthesized Cox1p forming a transient complex that is stabilized by Cox14p. A downstream event, maybe catalyzed by
Shy1p, causing Cox1p to dissociate from the ternary complex makes Mss51p available for new rounds of translation. To simplify the model
we have not included the action of Mss51p on the coding sequence of COX1, probably on Cox1p itself, interpreted as necessary for elongation
of the nascent polypeptide (Perez-Martinez et al., 2003). In mss51 mutants (mss51) Mss51p-independent translation from alternate initiation
sites in a COX1 mRNA precursor occur generating a new polypeptide, mp15, which is proteolytically degraded.
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chains has been reported previously (for review, see Tenson
and Ehrenberg, 2002).
The mp15 polypeptide is most evident in mss51 mutant
containing mtDNA of W303, to a lesser extent in mss51
mutants with D273 mtDNA, and it is not detected in strains
with an intronless COX1 or with combinations of introns
other than those of W303 and D273. The appearance of novel
mitochondrial translation products has been reported pre-
viously. For example, a cox1 mutant expressing both Pet309p
and Mss51p but defective in intron aI1 splicing was shown to
produce a 90-kDa protein translated from the continuous read-
ing frame encoded by the first exon and part of the first intron
of COX1. This protein is post-translationally cleaved into
two polypeptides of 20 and 68 kDa, the latter constituting
the maturase encoded by intron aI1 (Carignani et al., 1983).
In contrast, synthesis of mp15 depends on the complete
absence of Mss51p or presence of only limiting amounts of
the translationally competent protein. That mp15 is not de-
tected in an mss51 null mutant with intronless mtDNA sup-
ports the notion that this protein is translated from a COX1
precursor transcript with one or more introns. The COX1
genes of W303 and D273 contain all three group II introns
(aI1, -2, and -5) and the group I intron aI3. The intron
composition of COX1 in D273 is similar to W303 except for
the presence of group I intron aI4, which seems to suppress
mp15 synthesis. It is also noteworthy that the only difference
between the COX1 genes of D273 and G1–224, which does
not express mp15, is the absence in the latter of intron aI5.
The lack of a clear correlation between the presence or
absence of a particular intron and mp15 synthesis suggests
that the overall intronic composition in the context of the
mss51 mutation may be crucial for the production or stability
of the transcript corresponding to the mp15 mRNA.
Cox1p synthesis is regulated by downstream events oc-
curring during assembly of the COX holoenzyme (Perez-
Martinez et al., 2003; Barrientos et al., 2004). In our model,
entry of newly translated Cox1p into the COX assembly
pathway depends on its interaction with Mss51p and
Cox14p (Figure 10). When engaged in this ternary complex,
Mss51p is forestalled from initiating new rounds of Cox1p
synthesis. Dissociation of Mss51p from the complex is envi-
sioned to occur when Cox1p acquires its prosthetic groups
or interacts with other COX subunits. This step may be
catalyzed by Shy1p (Perez-Martinez et al., 2003; Barrientos et
al., 2004). This is supported by the severe repression of
Cox1p translation in mutants that are blocked in COX as-
sembly (Barrientos et al., 2004), in which mp15 is also syn-
thesized because in these strains the amount of Mss51p
available for normal COX1 mRNA translation is limited. The
single exception are cox14 mutants, in which normal
amounts of Cox1p are synthesized and Mss51p is available for
translation even in the absence of COX assembly (Barrientos et
al., 2004). For simplicity, our model depicted in Figure 10
does not include the role of Mss51p on the coding sequence
of COX1 mRNA. As mentioned above, the interaction of
Mss51p with Cox1p itself could be necessary for elongation
of the nascent polypeptide and it could in addition regulate
Cox1p synthesis (Perez-Martinez et al., 2003).
The regulatory model portrayed in Figure 10 is also sup-
ported by the results presented here. Synthesis of mp15 is
Pet309p-dependent and Mss51p-independent, whereas syn-
thesis of Cox1p requires both translational factors (Figure
10). Cox1p and mp15 synthesis are inversely related, sug-
gesting that synthesis of Cox1p may suppress Mss51p-inde-
pendent translation from alternate initiation sites by com-
peting for Pet309p. Translation of mp15 in COX assembly
mutants (not depicted in Figure 10 for simplicity) also points
to the existence of a Cox14p-stabilized Mss51p-Cox1p com-
plex. When trapped in this complex Mss51p is unavailable
for translation of Cox1p. Mutations in COX14, either alone
or in combination with mutations in other COX assembly
factors (except MSS51), inhibit synthesis of mp15. This is
consistent with the model as the instability of the Mss51p-
Cox1p complex in the absence of Cox14p would be expected
to make more Mss51p available for translation of Cox1p. The
lack of an effect on mp15 synthesis of overexpression or
deletion of COX14 in an mss51 null mutant, indicates that
Cox14p does not directly repress Cox1p synthesis but rather
does so indirectly by limiting Mss51p available for transla-
tion. Finally, incubation of cells in the presence of CAP
before the [35S]methionine pulse enhances synthesis of
Cox1p in most COX assembly mutants. This may be ex-
plained by the synthesis of extra Mss51p during the CAP
preincubation leading to enhanced translation of Cox1p,
whereas having the opposite effect on mp15.
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